Comparison of DNA extraction methods for COVID-19 host genetics studies

Ronaldo Celerino da Silva1, Suelen Cristina de Lima1, Wendell Palôma Maria Dos Santos Reis1,2

  • 1Department of Virology and Experimental Therapy (LAVITE), Aggeu Magalhães Institute (IAM), Oswaldo Cruz Foundation (Fiocruz), Recife, Pernambuco, Brazil.

Plos One
|October 30, 2023
PubMed

Insights

The Chelex®100 resin method is the most cost-effective and efficient for extracting DNA from COVID-19 patient samples. This DNA extraction technique provides high yield and quality, crucial for genetic studies, especially in resource-limited settings.

Area of Science:

  • Genetics
  • Molecular Biology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic highlighted global shortages in diagnostic supplies, particularly in developing nations.
  • Host genetics are increasingly recognized as a factor influencing COVID-19 severity and outcomes.
  • Accurate DNA extraction is fundamental for identifying genetic factors in SARS-CoV-2 infection.

Purpose of the Study:

  • To compare the efficacy of three DNA extraction methods for COVID-19 host genetic studies.
  • To evaluate methods based on cost, time, DNA yield, quality, and suitability for genetic analysis.
  • To identify an optimal DNA extraction strategy for nasopharyngeal samples in COVID-19 research.

Main Methods:

  • Comparison of Chelex®100 resin, phenol-chloroform, and QIAamp DNA extraction kit.
  • Evaluation of DNA extraction from nasopharyngeal samples of COVID-19 patients.
  • Assessment criteria included procedural steps, handling time, DNA quantity, DNA quality, and downstream application compatibility.

Main Results:

  • Chelex®100 was the most economical, costing 33x less than the commercial kit and 13x less than phenol-chloroform.
  • Chelex®100 yielded significantly more DNA (306x and 69x higher than the kit and phenol-chloroform, respectively).
  • This method required fewer handling steps and provided sufficient DNA quality for genetic studies.

Conclusions:

  • Chelex®100 resin is a superior method for DNA extraction from COVID-19 nasopharyngeal samples.
  • It offers an inexpensive, safe, simple, and fast alternative for genetic research.
  • This method is particularly advantageous for developing countries facing material processing constraints.